Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Range Cancer Therapeutics Index ETF CNCR

Full chart Compare
Set alert

Price alert · CNCR

All alert types
9.02 USD +0.14 (+1.58%)

At closeMay 27, 2025, 4:00 PM EDT

9.02 Day range 9.41
11.86 52-week range 17.96
YTD
-26.73%
1 year
-34.26%

Loncar Cancer Immunotherapy ETF

Issuer
—
Asset class
Equity
Expense ratio
0.79%
Assets under management
$12.73M
NAV
13.68
Holdings
31
Inception
2015-10-14
Top 10 weight
34.44%

Top holdings

  1. TIL Instil Bio, Inc. 3.59%
  2. REPL Replimune Group, Inc. 3.54%
  3. IOVA Iovance Biotherapeutics, Inc. 3.47%
  4. ZYME Zymeworks Inc. 3.45%
  5. ARGX argenx SE 3.42%
  6. GMAB Genmab A/S 3.42%
  7. BMY Bristol-Myers Squibb Company 3.39%
  8. CRSP CRISPR Therapeutics AG 3.39%
  9. AZN AstraZeneca PLC 3.39%
  10. MRK Merck & Co., Inc. 3.37%
  11. XNCR Xencor, Inc. 3.37%
  12. NKTR Nektar Therapeutics 3.37%
  13. REGN Regeneron Pharmaceuticals, Inc. 3.36%
  14. GILD Gilead Sciences, Inc. 3.33%
  15. FATE Fate Therapeutics, Inc. 3.33%
  16. RCUS Arcus Biosciences, Inc. 3.32%
  17. ATRA Atara Biotherapeutics, Inc. 3.30%
  18. TRIL Trillium Therapeutics Inc. 3.29%
  19. RUBY Rubius Therapeutics, Inc. 3.29%
  20. ALLO Allogene Therapeutics, Inc. 3.29%
  21. IBRX ImmunityBio, Inc. 3.28%
  22. BLUE bluebird bio, Inc. 3.28%
  23. IMAB I-Mab 3.25%
  24. IGMS IGM Biosciences, Inc. 3.23%
  25. STTK Shattuck Labs, Inc. 3.23%

Updated 2024-08-12